PD-1 knockout TILs for advanced colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new therapy where immune cells (TILs) from your tumor are modified to fight cancer more effectively. It's for people with advanced colorectal cancer who can't get standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced colorectal cancer that standard treatments can't help anymore.
- You're willing to have surgery or a biopsy to get tumor tissue for making the treatment.
- You are between 18 and 70 years old.
- At least one tumor that can be measured by scans.
- You're in fairly good physical condition (able to do daily activities).
- Your organs (bone marrow, liver, kidneys) must be working well enough.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This Phase 2 trial studies a combination treatment that includes anti-PD-1 immunotherapy for rectal cancer that has spread to the liver or lungs but can still be surgically removed. It aims to improve outcomes compared with a standard approach by using immune therapy as part of treatment before/around surgery.
This trial tests whether your own immune cells, called tumor-infiltrating lymphocytes (TILs), can be grown in a lab and given back to you to fight advanced colorectal cancer. It is for people whose cancer has continued to grow after their first round of chemotherapy.
This trial tests a new type of immune cell therapy (gamma-delta T cells that have been modified to target PD-1) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if these cells can help your immune system fight the cancer.
This trial tests a treatment made from your own immune cells (called TILs) that are taken from your tumor, grown in a lab, and given back to you along with immunotherapy. It is for people with advanced colon or rectum cancer who have run out of standard options.
This study tests an immune-cell treatment made from your tumor tissue. It aims to help people with advanced or metastatic triple-negative breast cancer by collecting PD-1–positive immune cells and giving them back after treatment.
Hear when a new Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.